Histamine H3 Receptor Antagonists: Preclinical Promise for Treating Obesity and Cognitive Disorders
Timothy A. Esbenshade · Molecular Interventions · 2006
The histamine H3 receptor is an attractive G protein-coupled receptor drug target that regulates neurotransmission in the central nervous system and plays a role in cognitive and homeostatic functions. Drug discovery efforts by numerous pharmaceutical companies have focused on the preclinical development of H3 receptor antagonists for the potential treatment of attention-deficit hyperactivity disorder, dementias, schizophrenia, as well as obesity and sleep disorders. This receptor exhibits molecular, pharmacological, and functional heterogeneity that informs the preclinical development of effective antagonists. Herein, we describe the biological and chemical implications for developing H3 receptor antagonists and their therapeutic potential as disclosed through animal models of cognition, sleep, and obesity.
Cited by 194 works. doi:10.1124/mi.6.2.5
Authors
References
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
- Highly potent and selective ligands for histamine H3-receptors
- Histaminergic transmission in the mammalian brain
- Cloning and Functional Expression of the Human Histamine H3Receptor
- The Epidemic of Obesity
- The physiology of brain histamine
- H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs
- High constitutive activity of native H3 receptors regulates histamine neurons in brain
- The histamine H3 receptor: from gene cloning to H3 receptor drugs
- Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist